References

1. Northcutt AR, Harding JP, Kong S, et al. Urgency as an endpoint in IBS. Gastroenterology 1999;116(4 part 2):A1036.
2. Data on file, Prometheus Laboratories Inc., San Diego, CA.
3. Lembo T, Wright RA, Bagby B, et al. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2001;96(9):2662-2670.